GlassScriptPhysician profile
B G Shily
NPI 1306975982
$1,549.58
in general payments reported to CMS, 2019-2025
11 companies · $68.05 in 2025
The $68.05 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,066 · 2021: $51.63 · 2022: $35.18 · 2023: $179 · 2024: $150 · 2025: $68.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328 · Entertainment: $69.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.79 |
| Entertainment | $69.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $394.68 | 2019 | |
| Optos, INC. | $198.00 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $173.53 | 2019-2021 | |
| Topcon Healthcare, INC. | $132.94 | 2019 | |
| Sun Pharmaceutical Industries INC. | $124.26 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $120.92 | 2019-2025 | Acuvue |
| Aerie Pharmaceuticals, INC. | $118.85 | 2019 | |
| Glaukos Corporation | $106.00 | 2023 | |
| Abbvie INC. | $76.55 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Lkc Technologies, INC. | $53.01 | 2024 | |
| Bausch & Lomb Americas INC. | $50.84 | 2023-2025 | Infuse, Biotrue, Biotrue One Day |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw B Shily listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.